Publication | Closed Access
Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers
30
Citations
29
References
2013
Year
Mirabegron 100 mg orally once daily for 8 weeks of treatment does not increase the IOP, and was generally safe and well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1